Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study.
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden.
A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis: The MusiQoL-MCAT.
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
Guillain-Barré syndrome in Colombia: where do we stand now?
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Transcriptional enhancers: from properties to genome-wide predictions.
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
mfERG_LAB: Software for processing multifocal electroretinography signals.
Rehabilitation in transverse myelitis.
The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.
PLEGRIDY™ (peginterferon beta-1a) approved in the European Union for the treatment of multiple sclerosis
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
Decreased Frontal Lobe Gray Matter Perfusion in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis Detected by the Bookend Technique.
Agreement between physician's recommendation and fitness-to-drive decision in multiple sclerosis.
Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.
MiR-126: a novel route for natalizumab action?
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis.
Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain.
Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells.

Pages